News | Cath Lab | August 22, 2016

DMC Heart Hospital Completes Complex High-Risk Indicated Interventional Procedure Course

Veteran interventional cardiologists and DMC Heart Hospital leadership offered four clinically complex PCI cases via live feed during the course

DMC Heart Hospital, Detroit Medical Center, complex percutaneous intervention education course, PCI, cath lab training

August 22, 2016 — The Detroit Medical Center (DMC) Heart Hospital recently completed a Complex Percutaneous Intervention education course, utilizing an unprecedented four live, clinically complex cases. Participating physicians included: DMC Heart Hospital President Theodore Schreiber, M.D.; Vice President Cindy Grines, M.D.,; Medical Director of the Cardiac Care Unit and Chief of Cardiology Mahir Elder, M.D.; Cardiac Catheterization Lab Medical Director Amir Kaki, M.D.; and Tamam Mohamad, M.D.

The Complete Revascularization of Higher Risk Patients (frequently abbreviated as “CHIP”) program is geared toward the interventionalist seeking to better understand complex percutaneous coronary intervention (PCI) in the modern era. Presentations address treatment of left main disease, chronic total occlusions, long lesions, bifurcation lesions, “small vessels” and saphenous vein grafts. In addition, participants learn how to manage challenging patient subsets, such as those with advanced heart failure, as well as how to provide optimal hemodynamic support.

The course is a combination of live complex cases, hands-on workstations and didactic. DMC provided four live complex cases; traditionally, most accounts only do one or two live cases. The cases are displayed via live video feed from the cardiac catheterization lab to the education room.

This course educated interventional physicians on an option for patients that are too sick for surgery or refuse surgery. By training other interventional cardiologists on why, how and which patients are U.S. Food and Drug Administration (FDA)-indicated for supported PCI, more heart failure patients can be treated effectively, versus being sent home on medical management. Additionally, the data shows when treated by supported PCI, these patients stay in the hospital for a shorter periods of time, they feel better once they leave and they experience less readmissions.

“No other Complex PCI CHIP course has ever demonstrated four live cases as complex as the ones showcased on Monday,” according to Schreiber. “However, it is not only the case complexity and the positive outcomes achieved, but the ability to engage the audience with questions, knowledge, charm and even some humor, which makes this course an impactful and memorable experience for all.”

For more information: www.dmc.org

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init